Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.159NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
FE.1.1.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
XBB.1.45.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
LE.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
AY.4.7 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
B.1.336NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
B.1.232NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15625.1US
XBB.1.41.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15620.7Singapore
BN.1.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15620.7Singapore
GS.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
JN.1.58.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
AY.122.5 (Delta)NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
KP.3.3.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
KP.3.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
KP.3.3.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
ML.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
KP.3.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
XBB.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
ML.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-15598.4US
P.1.16 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-15597.1Singapore
EG.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15597.1Singapore
AY.44 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-15597.1Singapore
AY.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-15597.1Singapore
B.1.1.263SYoung-STATACATGTCTCTGGGACCA20452176321782F-15593.6Singapore
B.50EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15585.8China
B.1.442NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-15565China
BA.5.2.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15533.3Singapore
BA.2.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15533.3Singapore
JN.5SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-15519.7Japan
B.19NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-15518.6US
XBC.1.6.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-15478.6South Korea
B.50ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-15465.7Germany
B.1.1.334NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15455.9China
XDQNCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15455.9China
XBB.1.16.11NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15429China
B.1.501ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15413.7France
XBB.1.5.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
AM.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
AM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
XBF.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
BA.2.75.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
BA.2.81ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15397.9France
B.1.1.430NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-15385China
XBB.1.38.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-15364Germany
XDZORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-15341.9South Korea
DV.7.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-15341.2China
BA.2.86.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-15341.2China
FL.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15334.4China
B.1.1.236SYoung-STATACATGTCTCTGGGACCA20452176321782F-15180.6Singapore
GK.11ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-15177.6Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used